Seeking Alpha

St. Jude Medical (STJ +3.5%) trades up after the FDA approves its Ellipse implantable...

St. Jude Medical (STJ +3.5%) trades up after the FDA approves its Ellipse implantable cardioverter defibrillator. Designed with feedback from more than 200 physicians, the Ellipse offers physicians unique advancements, and is designed to increase patient comfort and physician ease-of-use. Separately, Morgan Stanley upgraded the shares to Overweight this morning, saying it expects the company to benefit from new cardio markets and reduced Durata concerns.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs